PITPNA and hepatocellular carcinoma: To explore whether the dysregulation of PITPNA-AS1 may influence the survivals of HCC patients, we performed Kaplan-Meier methods, finding that the 5-years overall survival (p = 0.0046) and disease-free survival (p = 0.0038) of high PITPNA-AS1 expression group were distinctly shorter than those of low PITPNA-AS1 expression group (Figure 1H).